Latest Headlines
-
Prometheus Laboratories Announces New Health Plan Agreements To Provide Precision-Guided Testing Services
5/9/2024
Prometheus Laboratories Inc. ("Prometheus"), a leader in precision medicine for immune-mediated diseases, announced the execution of provider agreements with three large regional health plans to facilitate access to PredictrPK, precision-guided biologic testing, and other Prometheus testing services to the participating health plans and their respective members.
-
ADLM Releases Guidance To Help Healthcare Professionals Navigate Respiratory Virus Testing In A Post-COVID World
5/9/2024
The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) has issued a new guidance document that provides expert recommendations on fundamental areas of clinical testing for respiratory viral infections.
-
Indica Labs Receives First FDA Clearance For HALO AP Dx Digital Pathology Platform
5/8/2024
Indica Labs, the leading provider of digital pathology solutions, announced today that it received FDA clearance for HALO AP Dx, an enterprise digital pathology platform, for primary diagnosis.
-
Orchard Software Partners With Luxor Scientific To Expand Testing Services
5/8/2024
Orchard Software is pleased to announce its collaborative test-expansion partnership with Luxor Scientific Medical Laboratories.
-
Biolabs International LLC Announces Exclusive Distribution Agreement With Watmind USA™ For Next-Generation Diagnostics Platform
5/8/2024
As the world eagerly anticipates advancements in diagnostics, Biolabs International LLC stands at the forefront of innovation with the announcement of an exclusive distribution agreement.
-
Waters ACQUITY QDa II Mass Detector Delivers Wider Range Of Chemical Analysis Within Cost-Effective, Lower Energy Instrument
5/8/2024
Waters Corporation (NYSE:WAT) today announced the release of the ACQUITY QDa II Mass Detector, the evolution of its highly successful, compact, and streamlined mass detection instrument that delivers high-quality, mass spectral data to chromatographic separations.
-
iHealth Unveils Breakthrough 3-In-1 At-Home 15-Minute Antigen Test For COVID-19 And Flu A&B
5/8/2024
iHealth Labs, Inc. (iHealth®), a leading provider of digital health solutions, today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the company's 3-in-1 COVID-19/Flu A&B Rapid Test Kit for self-testing at home, with results in 15 minutes.
-
Beckman Coulter And MeMed Extend Partnership Advancing Host Immune Response Diagnostics
5/7/2024
Beckman Coulter Diagnostics, a global leader in clinical diagnostics, and MeMed, a leader in the emerging field of advanced host-response technologies, today announced expansion of their host immune response diagnostics partnership.
-
FDA Approves ColoSense – Geneoscopy's Noninvasive Multi-Target Stool RNA (mt-sRNA) Colorectal Cancer Screening Test
5/6/2024
Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced that the U.S. Food and Drug Administration (FDA) approved its noninvasive colorectal cancer screening test, ColoSense.
-
Vesica Health Announces Launch Of AssureMDx Test To Improve Bladder Cancer Detection
5/3/2024
VESICA HEALTH, INC., a leading multi-omics liquid biopsy company dedicated to improving the management of hematuria patients and the early detection of bladder cancer, today announced the launch of its laboratory-developed AssureMDx™ test.